Case Note & Summary
The appellant, a pharmaceutical company, challenged demand notices issued by the National Pharmaceutical Pricing Authority (NPPA) under the Drugs (Price Control) Order, 1995 (DPCO), seeking recovery of overcharged amounts for its drug formulation 'Roscilox' (a Cloxacillin-based drug). The NPPA claimed that the appellant had charged prices higher than those fixed by the Government for the period April 1996 to July 2003, resulting in an overcharged principal of ₹2,15,62,077 and interest of ₹2,49,46,256, totaling ₹4,65,08,333. The appellant had already paid ₹1.25 crores. The appellant's writ petition before the Delhi High Court was dismissed by a single judge, and the subsequent Letters Patent Appeal was also dismissed by a Division Bench. The appellant then appealed to the Supreme Court. The core legal issue was whether the appellant, which claimed to be only a 'dealer' and not a 'manufacturer', 'importer', or 'distributor', could be subjected to recovery proceedings under Paragraph 13 of the DPCO. The appellant argued that Paragraph 13 only applies to manufacturers, importers, or distributors, and that as a mere dealer, it was outside its scope. The NPPA contended that the appellant acted as a distributor, given its direct purchase from the manufacturer and its role in the supply chain. The Supreme Court analyzed the definitions under the DPCO, noting that the definitions of 'dealer', 'distributor', and 'wholesaler' are overlapping and not mutually exclusive. The Court observed that the appellant had admitted purchasing the drug directly from the manufacturer, Oscar Laboratories Pvt. Ltd., and later introduced an inconsistent version involving Delta Aromatics Pvt. Ltd. The appellant failed to produce any agreement with the manufacturer, leading to an adverse inference. The Court held that the appellant's role as a distributor was evident, and it could not escape liability under Paragraph 13. The Court also rejected the appellant's attempt to raise new grounds regarding the validity of the demand and computation under Paragraph 19, as these were not pleaded before the High Court. The Supreme Court dismissed the appeal, vacated the status quo order, and directed the appellant to bear its own costs.
Headnote
A) Drugs Price Control - Recovery of Overcharged Amount - Paragraph 13 of DPCO 1995 - Applicability to Dealers - The appellant claimed it was only a dealer and not a manufacturer, importer, or distributor, and thus not liable under Paragraph 13. The Supreme Court held that the definitions of 'dealer', 'distributor', and 'wholesaler' under DPCO 1995 are overlapping and not mutually exclusive. Given the appellant's direct purchase from the manufacturer and its role in marketing, it fell within the ambit of Paragraph 13. The Court emphasized a purposive interpretation to achieve the objective of price control for essential drugs. (Paras 10-11) B) Drugs Price Control - Burden of Proof - Failure to Produce Agreement - The appellant failed to produce the agreement with the manufacturer despite opportunities. The Court drew an adverse inference, noting that the appellant's inconsistent versions (initially claiming purchase from Oscar Laboratories, later from Delta Aromatics) undermined its claim of being only a dealer. (Paras 12-13) C) Civil Procedure - New Pleas - Not Permitted at Appellate Stage - The appellant sought to raise new grounds regarding validity of demand and computation under Paragraph 19 of DPCO 1995, which were not pleaded before the High Court. The Supreme Court declined to entertain these pleas, as they were raised for the first time during arguments before the Division Bench. (Paras 7-8)
Issue of Consideration
Whether the appellant, who claimed to be only a dealer and not a manufacturer, importer, or distributor, could be proceeded against under Paragraph 13 of the Drugs (Price Control) Order, 1995 for recovery of overcharged amounts.
Final Decision
The Supreme Court dismissed the appeal, holding that the appellant is liable under Paragraph 13 of DPCO 1995. The order of status quo dated 10.11.2014 was vacated. Pending applications dismissed. Parties to bear their own costs.
Law Points
- Paragraph 13 of DPCO 1995 applies to dealers and distributors alike
- not just manufacturers or importers
- overlapping definitions do not exclude liability
- purposive interpretation of price control provisions
- failure to produce agreement with manufacturer leads to adverse inference
- inconsistent versions by appellant disentitle it from claiming exemption.
